PT  - JOURNAL ARTICLE
AU  - R. Piltch-Loeb
AU  - E. Savoia
AU  - B. Goldberg
AU  - B. Hughes
AU  - T. Verhey
AU  - J. Kayyem
AU  - C. Miller-Idriss
AU  - MA. Testa
TI  - Examining the effect of information channel on COVID-19 vaccine acceptance
AID  - 10.1101/2021.01.18.21250049
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.18.21250049
4099  - http://medrxiv.org/content/early/2021/01/20/2021.01.18.21250049.short
4100  - http://medrxiv.org/content/early/2021/01/20/2021.01.18.21250049.full
AB  - Hesitancy towards the COVID-19 vaccine remains high among the US population. Now that the vaccine is available to priority populations, it is critical to convince those that are hesitant to take the vaccine. Public health communication about the vaccine as well as misinformation on the vaccine occurs through a variety of different information channels. Some channels of information are more commonly found to spread misinformation. Given the expansive information environment, we sought to characterize the use of different media channels for COVID-19 vaccine information and determine the relationship between information channel and vaccine acceptance. We conducted a convenience sample of vaccine priority groups (N=2,650) between December 13 and 23, 2020 and conducted bivariate chi-squared tests and multivariable multinomial logistic regression analyses to determine the relative impact of channels of information on vaccine acceptance. We found traditional channels of information, especially National TV, National newspapers, and local newspapers increased the relative risk of vaccine acceptance. Individuals who received information from traditional media compared to social media or both traditional and social media were most likely to accept the vaccine. The implications of this study suggest social media channels have a role to play in educating the hesitant to accept the vaccine, while traditional media channels should continue to promote data-driven and informed vaccine content to their viewers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by Jigsaw, Google. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsor.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board at the Harvard T.H. Chan School of Public Health Office of Regulatory Affairs and Research Compliance 90 Smith Street, 3rd Floor Boston, MA 02120 Federal wide Assurance # FWA00002642All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request from the authors.